OBJECTIVE: To review the evidence on and estimate the risk of myocardial infarction and stroke in bipolar disorder. METHOD: A systematic search using MEDLINE, EMBASE, PsycINFO, Web of Science, Scopus, Cochrane Database of Systematic Reviews, and bibliographies (1946 - May, 2013) was conducted. Case-control and cohort studies of bipolar disorder patients age 15 or older with myocardial infarction or stroke as outcomes were included. Two independent reviewers extracted data and assessed quality. Estimates of effect were summarized using random-effects meta-analysis. RESULTS: Five cohort studies including 13 115 911 participants (27 092 bipolar) were included. Due to the use of registers, different statistical methods, and inconsistent adjustment for confounders, there was significant methodological heterogeneity among studies. The exploratory meta-analysis yielded no evidence for a significant increase in the risk of myocardial infarction: [relative risk (RR): 1.09, 95% CI 0.96-1.24, P = 0.20; I(2) = 6%]. While there was evidence of significant study heterogeneity, the risk of stroke in bipolar disorder was significantly increased (RR 1.74, 95% CI 1.29-2.35; P = 0.0003; I(2) = 83%). CONCLUSION: There may be a differential risk of myocardial infarction and stroke in patients with bipolar disorder. Confidence in these pooled estimates was limited by the small number of studies, significant heterogeneity and dissimilar methodological features.
OBJECTIVE: To review the evidence on and estimate the risk of myocardial infarction and stroke in bipolar disorder. METHOD: A systematic search using MEDLINE, EMBASE, PsycINFO, Web of Science, Scopus, Cochrane Database of Systematic Reviews, and bibliographies (1946 - May, 2013) was conducted. Case-control and cohort studies of bipolar disorderpatients age 15 or older with myocardial infarction or stroke as outcomes were included. Two independent reviewers extracted data and assessed quality. Estimates of effect were summarized using random-effects meta-analysis. RESULTS: Five cohort studies including 13 115 911 participants (27 092 bipolar) were included. Due to the use of registers, different statistical methods, and inconsistent adjustment for confounders, there was significant methodological heterogeneity among studies. The exploratory meta-analysis yielded no evidence for a significant increase in the risk of myocardial infarction: [relative risk (RR): 1.09, 95% CI 0.96-1.24, P = 0.20; I(2) = 6%]. While there was evidence of significant study heterogeneity, the risk of stroke in bipolar disorder was significantly increased (RR 1.74, 95% CI 1.29-2.35; P = 0.0003; I(2) = 83%). CONCLUSION: There may be a differential risk of myocardial infarction and stroke in patients with bipolar disorder. Confidence in these pooled estimates was limited by the small number of studies, significant heterogeneity and dissimilar methodological features.
Authors: Frank Bellivier; Jean-Louis Golmard; Marcella Rietschel; Thomas G Schulze; Alain Malafosse; Martin Preisig; Patrick McKeon; Lesley Mynett-Johnson; Chantal Henry; Marion Leboyer Journal: Am J Psychiatry Date: 2003-05 Impact factor: 18.112
Authors: C Torrent; B Amann; J Sánchez-Moreno; F Colom; M Reinares; M Comes; A R Rosa; J Scott; E Vieta Journal: Acta Psychiatr Scand Date: 2008-05-22 Impact factor: 6.392
Authors: Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: Isabelle E Bauer; Juan F Gálvez; Jane E Hamilton; Vicent Balanzá-Martínez; Giovana B Zunta-Soares; Jair C Soares; Thomas D Meyer Journal: J Psychiatr Res Date: 2015-12-12 Impact factor: 4.791
Authors: Christoph U Correll; Marco Solmi; Nicola Veronese; Beatrice Bortolato; Stella Rosson; Paolo Santonastaso; Nita Thapa-Chhetri; Michele Fornaro; Davide Gallicchio; Enrico Collantoni; Giorgio Pigato; Angela Favaro; Francesco Monaco; Cristiano Kohler; Davy Vancampfort; Philip B Ward; Fiona Gaughran; André F Carvalho; Brendon Stubbs Journal: World Psychiatry Date: 2017-06 Impact factor: 49.548
Authors: Moein Foroughi; Jose R Medina Inojosa; Francisco Lopez-Jimenez; Farzane Saeidifard; Laura Suarez; Gorazd B Stokin; Miguel L Prieto; Walter A Rocca; Mark A Frye; Robert J Morgan Journal: Psychosom Med Date: 2022-01-01 Impact factor: 4.312
Authors: Miguel L Prieto; Louis A Schenck; Jennifer L Kruse; James P Klaas; Alanna M Chamberlain; William V Bobo; Frank Bellivier; Marion Leboyer; Véronique L Roger; Robert D Brown; Walter A Rocca; Mark A Frye Journal: J Affect Disord Date: 2016-01-13 Impact factor: 4.839
Authors: Emma K Stapp; Stacey C Williams; Luther G Kalb; Calliope B Holingue; Kathryn Van Eck; Elizabeth D Ballard; Kathleen R Merikangas; Joseph J Gallo Journal: J Psychosom Res Date: 2020-07-28 Impact factor: 3.006
Authors: Maria A I Åberg; Kjell Torén; Michael Nilsson; Malin Henriksson; H Georg Kuhn; Jenny Nyberg; Annika Rosengren; N David Åberg; Margda Waern Journal: Stroke Date: 2016-02-04 Impact factor: 7.914